Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs

被引:20
作者
Carneiro, Claudia Martins
Martins-Filho, Olindo Assis
Reis, Alexandre Barbosa
Veloso, Vanja Maria
Gomes Araujo, Flavio Marcos
Bahia, Maria Terezinha
de Lana, Marta
Lins Machado-Coelho, George Luiz
Gazzinelli, Giovanni
Correa-Oliveira, Rodrigo
Tafuri, Washington Luiz
机构
[1] Univ Fed Ouro Preto, Escola Farm, Dept Anal Clin, BR-35400000 Ouro Preto, MG, Brazil
[2] Univ Fed Ouro Preto, Lab Imunopatol, BR-35400000 Ouro Preto, MG, Brazil
[3] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Doenca Chagas, Belo Horizonte, MG, Brazil
[4] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol & Biol Mol, Belo Horizonte, MG, Brazil
[5] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Dept Ciencias Biol, BR-35400000 Ouro Preto, MG, Brazil
[6] Univ Fed Ouro Preto, Parasitol Lab, BR-35400000 Ouro Preto, MG, Brazil
[7] Univ Fed Ouro Preto, Lab Epidemiol, BR-35400000 Ouro Preto, MG, Brazil
[8] Univ Fed Ouro Preto, Escola Farm, Dept Farm, BR-35400000 Ouro Preto, MG, Brazil
关键词
dog; blood (BT) and metacyclic (MT) trypomastigotes; Trypanosoma cruzi; flow cytometry;
D O I
10.1016/j.actatropica.2006.12.009
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
A detailed follow-up investigation of the major parasitological, serological and phenotypic features in dogs experimentally infected with metacyclic (NIT) and blood (BT) trypornastigotes of Trypanosoma cruzi strain Berenice-78, typifying vectorial and transfusional transmission of human Chagas disease, has been conducted. Although there were no changes with respect to the window of patent-parasitaemia, significant differences between MT- and BT-infected dogs in both the prepatent period (days 23 and 19, respectively) and the day of maximum parasitaemia (days 26 and 22, respectively) were recorded. A progressive enhancement in the level of T cruzi-specific antibodies accompanied infection by both MT and BT forms, although higher IgG titres developed on days 14 and 21 following infection with NIT forms. Higher Thy-1(+)/CD21(+) and lower CD4(+)/CD8(+) cell ratios, occasioned by increased levels of Thy-1(+) and CD8(+) T-cells and reduced frequencies of CD4(+) T-cells and CD21(+) B-lymphocytes, were observed in both MT- and BT-infected animals. The reduced frequency of CD 14' leukocytes was revealed as the most relevant phenotypic feature intrinsic to T cruzi infection independent of inoculum source. BT-specific phenotypic features included an early reduction in the percentage of circulating CD21(+) and CD14(+) leukocytes, together with a higher Thy-1(+)/CD21(+) cell ratio on day 42. On the other hand, higher levels of CD8(+) T-cells, together with a lower CD4(+)/CD8(+) cell ratio on day 28, were characteristic of MT infection. These findings emphasise the importance of inoculum source and suggest that vectorial or transfusional routes of T cruzi infection may trigger distinct parasite-host interactions during acute Chagas disease. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:120 / 129
页数:10
相关论文
共 35 条
[1]   The Trypanosoma cruzi-host-cell interplay:: location, invasion, retention [J].
Andrade, LO ;
Andrews, NW .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (10) :819-823
[2]  
[Anonymous], 1983, Statistical methods
[3]   AN FC-GAMMA-RII-SPECIFIC, FC-GAMMA-RIII-SPECIFIC MONOCLONAL-ANTIBODY (2.4G2) DECREASES ACUTE TRYPANOSOMA-CRUZI INFECTION IN MICE [J].
ARAUJOJORGE, T ;
RIVERA, MT ;
ELBOUHDIDI, A ;
DAERON, M ;
CARLIER, Y .
INFECTION AND IMMUNITY, 1993, 61 (11) :4925-4928
[4]  
Bahia Maria Terezinha, 2002, Rev. Soc. Bras. Med. Trop., V35, P339, DOI 10.1590/S0037-86822002000400010
[5]  
Bento CAM, 1996, J IMMUNOL, V157, P4996
[6]  
BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389
[7]   Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease [J].
Brener, Z ;
Gazzinelli, RT .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 114 (02) :103-110
[8]   Immunohistochemical studies in acute and chronic canine chagasic cardiomyopathy [J].
Caliari, MV ;
de Lana, M ;
Cajá, RAF ;
Santos, CAB ;
Magalhaes, GA ;
Sampaio, IBM ;
Tafuri, WL .
VIRCHOWS ARCHIV, 2002, 441 (01) :69-76
[9]  
Camargo MM, 1997, J IMMUNOL, V158, P5890
[10]  
Conover W. J., 1980, PRACTICAL NONPARAMET